Abstract:Necroptosis is a caspase-independent modality of cell death implicated in many inflammatory pathologies. The execution of this pathway requires the formation of a cytosolic platform that comprises RIPK1 and RIPK3 which, in turn, mediates the phosphorylation of the pseudokinase MLKL (S345 in mouse). The activation of this executioner is followed by its oligomerisation and accumulation at the plasma-membrane where it leads to cell death via plasma-membrane destabilisation and consequent permeabilisation. While the biochemical and cellular characterisation of these events have been amply investigated, the study of necroptosis involvement in vivo in animal models is currently limited to the use of Mlkl −/− or Ripk3 −/− mice. Yet, even in many of the models in which the involvement of necroptosis in disease aetiology has been genetically demonstrated, the fundamental in vivo characterisation regarding the question as to which tissue(s) and specific cell type(s) therein is/are affected by the pathogenic necroptotic death are missing. Here, we describe and validate an immunohistochemistry and immunofluorescence-based method to reliably detect the phosphorylation of mouse MLKL at serine 345 (pMLKL-S345). We first validate the method using tissues derived from mice in which Caspase-8 (Casp8) or FADD are specifically deleted from keratinocytes, or intestinal epithelial cells, respectively. We next demonstrate the presence of necroptotic activation in the lungs of SARS-CoV-infected mice and in the skin and spleen of mice bearing a Sharpin inactivating mutation. Finally, we exclude necroptosis occurrence in the intestines of mice subjected to TNF-induced septic shock. Importantly, by directly comparing the staining of pMLKL-345 with that of cleaved Caspase-3 staining in some of these models, we identify spatio-temporal and functional differences between necroptosis and apoptosis supporting a role of RIPK3 in inflammation independently of MLKL versus the role of RIPK3 in activation of necroptosis.

What problem does this paper attempt to address?

The main problem this paper attempts to address is the development of a reliable and reproducible method to detect necroptosis occurring in mice. Specifically, the researchers developed an immunohistochemistry and immunofluorescence method to specifically detect the phosphorylation state of the serine 345 site of the mouse MLKL protein (pMLKL-S345) in different tissues. Through this method, researchers are able to distinguish necroptosis from other forms of cell death such as apoptosis, and further explore the mechanisms of necroptosis in various disease models and its relationship with inflammation. By optimizing experimental conditions, the study validated the effectiveness and specificity of the developed method and applied it to several different animal models, including tissues such as skin, intestine, lung, spleen, and liver, to demonstrate the applicability and advantages of this method under different pathological conditions. Additionally, the study compared the detection results of pMLKL-S345 with cleaved Caspase-3 (c-Casp3) in these models, emphasizing the importance of specifically detecting pMLKL-S345 to better understand the different patterns of cell death and their functional differences.

The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Dynamics of necroptosis in kidney ischemia-reperfusion injury

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

An immunohistochemical atlas of necroptotic pathway expression

Mlkl Knockout Mice Demonstrate the Indispensable Role of Mlkl in Necroptosis

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis

Biological events and molecular signaling following MLKL activation during necroptosis

Structural Insights into RIP3-Mediated Necroptotic Signaling

Necroptosis in health and diseases

A Putative Serine Protease is Required to Initiate the RIPK3-MLKL—Mediated Necroptotic Death Pathway in Neutrophils

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis